REACT Group plc cleaning up after another contract win for major hospital
Proactive takes a look at some movers and shakers throughout the day in London
Company
Verona Pharma
LON:VRP
Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, cystic fibrosis and asthma. The Company is listed on the Nasdaq Global Market in the United States under the VRNA ticker and on the London Stock Exchange in the United Kingdom under the VRP.L ticker. Read more here about Verona Pharma's science and innovative therapeutics.
58 stories · page 3 of 3
Archive
Paddy Power Betfair and the final hurdle for CEO Breon Corcoran
Is Corcoran leaving on a high or getting out while the going's good?
Archive
A kick in the gear-box for insurers but great news for personal injury victims
Trending: Car insurers dented ; EU to kibosh German takeover of iconic UK organisation; Persimmon blooms; Verona blossoms
Riser and fallers: Laird, Travis Perkins, Highland...
Highland shares got a boost after the company successfully proved the effectiveness of its DT Ultravert 'anti-bashing' technology
London stocks hold onto gains as Brexit fears fade
The FTSE100 held onto most of its intraday gains to close over 3% higher on Monday after sentiment towards remaining in the EU grew
Risers & Fallers: Ascent Resources, Hummingbird, Mkango ...
The European oil and gas exploration and production company Ascent lived up to its name as resolutions 1 to 3 were duly passed at today’s AGM.
NASDAQ listing for Verona Pharma?
Shares rose more than 20% after an oversubscribed placing raised £44.7mln to fund its lung disease drug.
FTSE 100 up 2% as 'remain' camp builds head of steam
The FTSE 100 opened strongly as predicted, with the opinion polls suggesting the ‘remain campaign’ has a narrow lead ahead of the crucial vote on Thursday.
Ireland-focused oil firms boosted as FTSE 100 Index rises
The FTSE 100 Index closed 24.02 points up at 6209.63
Verona Pharma reports progress but losses rise
Drug group reported progress in developing its lung disease treatment
Investments and investor services
Aim 100 edges higher while the Footsie takes a dip
The Footsie followed Asia's lead after the BoJ left its policies unchanged, but Aim moved higher, led by Sirius Minerals
Investments and investor services
Risers & Fallers: Findel, Sports Direct, Sovereign Mines of Africa, Alexander Mining, Cyan Holdings
Below are the main news-driven share price movements at 3.30pm.
Tuesday's agenda: Berkeley kicks off busy week for housebuilders
Berkeley and Whitbread are scheduled to release trading updates on Tuesday,
Investments and investor services
Risers & fallers: Hardide, Mobile Streams, Auhua Clean Energy, Verona Pharma
Auhua Energy rebounded while Urals Energy jumped ahead of its final results on Friday.